High level of HTRA3 expression was correlated with poor prognosis of GC in stage III – IV, T4, N2-3, and M0 subgroups, with the highest HR for poor OS, DSS, and PFI when HTRA3 was highly expressed in GC. Here, HTRA3 is linked to gastric cancer.